Navigation Links
Curry Better Than Aspirin For Headaches

If you have a brain-crushing headache, you are probably better off eating a bowl of steaming curry rather than swallowing the regulatory doses of aspirin, according// to a new study funded by the Scottish Executive. The study found that salicylic acid, the active ingredient in aspirin, is naturally available in certain Indian spices like cumin, turmeric and paprika, all of which are vital ingredients in a curry.

Researchers at the Rowett Research Institute said that curry does not cause side effects like internal bleeding and ulcers, which are common with long-term aspirin use. “One portion of vindaloo we examined contained 95mg of salicylic acid, more than the amount in an aspirin tablet. A low-dose aspirin tablet contains about 65mg of the acid," the researchers added.

Curcumin, which is found abundantly in turmeric, is thought to be responsible for this healthy effect. “The dietary level of salicylic acid in curry is exceptionally high. I wouldn’t recommend a curry a day for headaches, but it is possible that someone with a headache who is a very good absorber of salicylic acid might find it went away if they had a vindaloo," said the study's lead author Professor Garry Duthie.

“The hotter the curry is, the greater the possible benefits. A korma, with relatively low levels of spices, would be less effective than a vindaloo or a phal, the hottest curry widely available in Britain”

Page: 1

Related medicine news :

1. Curry Powder (haldi or turmeric) can prevent cancer
2. Simmering Curry - Murg Masala Embroiled In a Thick Soup
3. Type 2 Diabetes Could Be Tackled Using Curry Colouring and Fat Mix
4. Curry Could Help Keep Off Alzheimer’
5. Chemical in Curry May Help Immune System Clear Plaques Found in Alzheimers
6. Better prostate cancer detection
7. Better Treatment for obesity
8. For a Better Memory
9. Baby Talk Better Than Adult Speech
10. Drug Combo Works Better for children with ADHD, Tics
11. Better skin with lasers
Post Your Comments:

(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: